Anna Alonso Saladrigues
Investigador pre-doc
Research group
Anna Alonso Saladrigues graduated in Medicine in 2008 at the Universitat Autònoma de Barcelona and she obtained a specialty in Pediatrics and Specific Areas in 2013 at the Universitat de Barcelona. In 2013, she finished the Master's Degree in Pediatric Hematology at the Universitat de Barcelona. She obtained the Postgraduate Master's Degree in "Research Methodology: Design and Statistics in Health Sciences" at the Universitat Autònoma de Barcelona in 2018.
She has focused her professional career in the field of hematology oncology and for the past 6 years she has been an assistant doctor at the Leukemia, Lymphoma and Histiocytosis Unit and a reference doctor at the CAR-T Unit of Hospital Sant Joan de Déu Barcelona since her creation.
Regarding therapeutic advances, she actively participates as a co-investigator in all clinical trials of CAR-T therapy at Hospital San Juan de Dios Barcelona, in clinical trials of hematology oncology, as well as in studies subsidized by official bodies.
Her postgraduate degree in applied statistics in health sciences has enabled her to perform the work of data manager of the unit and collaborate in the statistical analysis of the national database of the SEHOP (Sociedad Española de Hematología y Oncología Pediátrica).
SJD Barcelona Children's Hospital Last Publications
- Alonso-Saladrigues A, Esperanza-Cebollada E, Vicente-Garces C, Pérez-Jaume S, Sánchez-Sierra N, Richarte M, Català-Temprano A, Crespo-Carrasco A, Dapena JL, Cuatrecasas E, Faura A, Ruiz-Cobo MA, Arqués L, Conde N, Andreu S, Isola I, Jordán-García I, Garcia-Rey E, Llanos C, Marsal-Ricoma J, Celis-Passini V, Camós-Guijosa M, Torrebadell-Burriel M, Vega-García N and Rives-Solà S Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy BONE MARROW TRANSPLANTATION . : .
- Rivera-Perez, Cristina, Morgades, Mireia, Alonso-Saladrigues A, Montesinos, Pau, Murciano, Thais, Gil, Cristina, Adan, Rosa, Esteve, Jordi, Fuentes, Carolina, Amigo, Maria Luz, Gonzalez-Martinez, Berta, Coll, Rosa, Dapena JL, de Llano, Maria Paz Queipo, Fuster, Jose Luis, Garcia-Cadenas, Irene, Tasso, Maria, Barba, Pere, Rives-Solà S and Ribera, Josep Maria Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups ANNALS OF HEMATOLOGY . 105(4): .
- Bartoló-Ibars A, Aran A, Johansson AM, Ortiz-Maldonado V, Klein-González N, Alonso-Saladrigues A, James E, Urbano-Ispizua A, Rives-Solà S, Delgado J, González-Navarro EA, Kwok WW and Juan-Otero M T-cell responses against CD19-targeted CAR T cells varnimcabtagene autoleucel (ARI-0001): implications for immune response and therapy outcomes Journal for ImmunoTherapy of Cancer . 13(9): .
Projects
- Project name:
- Estudio multicéntrico fase II para evaluar la eficacia y seguridad de ARI-0001 en pacientes pediátricos (0-18 años) con leucemia linfoblástica aguda B CD19+ en primera recaída o refractariedad
- Leader
- Susana Rives Solà
- Funding entities:
- Fundacio Privada Bosch y Aymerich
- Code
- PCP00480
- Starting - finishing date:
- 2026 - 2027
- Project name:
- ADVANCED THERAPIES (RICORS-TERAV)
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- RD24/0014/0006
- Starting - finishing date:
- 2025 - 2027
- Project name:
- Análisis de los factores pronósticos de fracaso del tratamiento tras terapia con células T con receptores antigénicos quiméricos (CAR-T) en pacientes pediátricos con leucemia linfoblástica aguda de línea B
- Leader
- Susana Rives Solà, Montserrat Torrebadell Burriel
- Funding entities:
- Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PI21/00218
- Starting - finishing date:
- 2022 - 2026
